Rosenblum Silverman Sutton’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.81M Buy
40,232
+175
+0.4% +$22.9K 1.26% 25
2025
Q4
$5.45M Sell
40,057
-1,130
-3% -$163K 1.26% 27
2025
Q3
$6.08M Buy
41,187
+175
+0.4% +$24.3K 1.39% 27
2025
Q2
$5.31M Sell
41,012
-220
-0.5% -$26.6K 1.29% 28
2025
Q1
$4.93M Buy
41,232
+202
+0.5% +$25K 1.36% 27
2024
Q4
$4.76M Sell
41,030
-10,425
-20% -$1.32M 1.2% 28
2024
Q3
$6.95M Buy
+51,455
New +$6.88M 1.78% 20

Other funds holding XYL

Rosenblum Silverman Sutton's XYL Position: Q1 2026 in Review

Rosenblum Silverman Sutton increased its Xylem (XYL) stake by 0.44% in Q1 2026, buying an estimated $22.9K and bringing the position to 40,232 shares worth $4.81M. The position accounts for 1.26% of the portfolio, ranked #25.

Rosenblum Silverman Sutton first reported a position in XYL in Q3 2024 and has held it in 7 quarters since. The position peaked at $6.95M in Q3 2024. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Rosenblum Silverman Sutton held 40,232 shares of Xylem worth $4.81M as of Q1 2026.
  • Rosenblum Silverman Sutton bought 175 Xylem shares in Q1 2026, an estimated $22.9K.
  • Xylem made up 1.26% of Rosenblum Silverman Sutton's portfolio in Q1 2026, its #25 holding.
  • Rosenblum Silverman Sutton first reported a position in Xylem in Q3 2024 and has held it in 7 quarters since.
  • Rosenblum Silverman Sutton's Xylem position peaked at $6.95M in Q3 2024.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Rosenblum Silverman Sutton's 13F filing for Q1 2026, filed 13 May 2026.